Terumo Corp ADR (TRUMY)

28.97 +0.30 (+1.05%)
Close USD Disclaimer
28.88 -0.09 (-0.31%)

Terumo Corp ADR Company Profile

Sector
Healthcare
Employees
28294
Equity Type
ADR
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
Contact Information
Address
Tokyo,151-0072 Japan
Phone
81 3 3374 8111
Fax
81 3 3374 8399
Top Executives
Name
Age
Since
Title
Shinjiro Sato 0 2014 President, CEO & Director
Shoji Hatano 63 2015 Group Senior Mng. Exe. Off. of Corporate Affairs Dept., Legal and Compliance Dept. & Director
Toshiaki Takagi 64 2010 Chairman of the Board & Senior Managing Executive Officer
Masaichi Nakamura 65 2019 Independent Outside Director
Hidenori Nishi 71 2020 Independent Outside Director
Yukiko Kuroda 59 2018 Independent Outside Director
Soichiro Uno 59 2019 Independent Outside Director
Takanori Shibazaki 61 2016 Director
Keiya Ozawa 69 2021 Independent Outside Director
Kyo Nishikawa 63 2016 Group Managing Executive Officer, Chief HR Officer & Director
Kazunori Hirose 58 2017 Managing Exe. off., GM of Prod., Procure. & Supply Chain, Chief Manufacturing Off. and Director
Koichi Sakaguchi 72 2022 Substitute Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles